David B. Hall

Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine

Jes Olesen, Hans‐Christoph Diener, Ingo W. Husstedt et al. · New England Journal of Medicine · 2004 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients

Julio Montaner, David A. Cooper, Stefano Vella et al. · JAMA · 1998 · 772 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16

Spin coating of thin and ultrathin polymer films

David B. Hall, Patrick T. Underhill, John M. Torkelson · Polymer Engineering and Science · 1998 · 516 citations

Natural Sciences, Materials Engineering, Materials Science +15

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Brian G. Feagan, William J. Sandborn, Geert D’Haens et al. · The Lancet · 2017 · 446 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

Dominique Baeten, Mikkel Østergaard, James Cheng‐Chung Wei et al. · Annals of the Rheumatic Diseases · 2018 · 374 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10